164 related articles for article (PubMed ID: 21456169)
21. Curcumin loaded pH-sensitive hybrid lipid/block copolymer nanosized drug delivery systems.
Jelezova I; Drakalska E; Momekova D; Shalimova N; Momekov G; Konstantinov S; Rangelov S; Pispas S
Eur J Pharm Sci; 2015 Oct; 78():67-78. PubMed ID: 26159739
[TBL] [Abstract][Full Text] [Related]
22. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
23. Curcumin liposomes prepared with milk fat globule membrane phospholipids and soybean lecithin.
Jin HH; Lu Q; Jiang JG
J Dairy Sci; 2016 Mar; 99(3):1780-1790. PubMed ID: 26774724
[TBL] [Abstract][Full Text] [Related]
24. Liposome encapsulation of curcumin: physico-chemical characterizations and effects on MCF7 cancer cell proliferation.
Hasan M; Belhaj N; Benachour H; Barberi-Heyob M; Kahn CJ; Jabbari E; Linder M; Arab-Tehrany E
Int J Pharm; 2014 Jan; 461(1-2):519-28. PubMed ID: 24355620
[TBL] [Abstract][Full Text] [Related]
25. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics.
Chen Y; Wu Q; Zhang Z; Yuan L; Liu X; Zhou L
Molecules; 2012 May; 17(5):5972-87. PubMed ID: 22609787
[TBL] [Abstract][Full Text] [Related]
26. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.
Mondal G; Barui S; Saha S; Chaudhuri A
J Control Release; 2013 Dec; 172(3):832-40. PubMed ID: 24036260
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis.
Ranjan AP; Mukerjee A; Helson L; Gupta R; Vishwanatha JK
Anticancer Res; 2013 Sep; 33(9):3603-9. PubMed ID: 24023285
[TBL] [Abstract][Full Text] [Related]
28. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
29. The combined effect of encapsulating curcumin and C6 ceramide in liposomal nanoparticles against osteosarcoma.
Dhule SS; Penfornis P; He J; Harris MR; Terry T; John V; Pochampally R
Mol Pharm; 2014 Feb; 11(2):417-27. PubMed ID: 24380633
[TBL] [Abstract][Full Text] [Related]
30. Effect of preparation techniques on the properties of curcumin liposomes: characterization of size, release and cytotoxicity on a squamous oral carcinoma cell line.
Gosangari SL; Watkin KL
Pharm Dev Technol; 2012; 17(1):103-9. PubMed ID: 21091385
[TBL] [Abstract][Full Text] [Related]
31. Magnetic cationic liposomal nanocarriers for the efficient drug delivery of a curcumin-based vanadium complex with anticancer potential.
Halevas E; Mavroidi B; Swanson CH; Smith GC; Moschona A; Hadjispyrou S; Salifoglou A; Pantazaki AA; Pelecanou M; Litsardakis G
J Inorg Biochem; 2019 Oct; 199():110778. PubMed ID: 31442839
[TBL] [Abstract][Full Text] [Related]
32. Revisiting the use of sPLA
Pourhassan H; Clergeaud G; Hansen AE; Østrem RG; Fliedner FP; Melander F; Nielsen OL; O'Sullivan CK; Kjær A; Andresen TL
J Control Release; 2017 Sep; 261():163-173. PubMed ID: 28662900
[TBL] [Abstract][Full Text] [Related]
33. Curcumin Nanotechnologies and Its Anticancer Activity.
Subramani PA; Panati K; Narala VR
Nutr Cancer; 2017 Apr; 69(3):381-393. PubMed ID: 28287321
[TBL] [Abstract][Full Text] [Related]
34. Fabrication and Characterization of Curcumin-Loaded Liposomes Formed from Sunflower Lecithin: Impact of Composition and Environmental Stress.
Peng S; Zou L; Liu W; Liu C; McClements DJ
J Agric Food Chem; 2018 Nov; 66(46):12421-12430. PubMed ID: 30372060
[TBL] [Abstract][Full Text] [Related]
35. Effective Skin Cancer Treatment by Topical Co-delivery of Curcumin and STAT3 siRNA Using Cationic Liposomes.
Jose A; Labala S; Ninave KM; Gade SK; Venuganti VVK
AAPS PharmSciTech; 2018 Jan; 19(1):166-175. PubMed ID: 28639178
[TBL] [Abstract][Full Text] [Related]
36. Co-Administration of Curcumin and Bromocriptine Nano-liposomes for Induction of Apoptosis in Lung Cancer Cells.
Sheikhpour M; Sadeghizadeh M; Yazdian F; Mansoori A; Asadi H; Movafagh A; Shahraeini SS
Iran Biomed J; 2020 Jan; 24(1):24-9. PubMed ID: 31454860
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of doxorubicin encapsulated in hexadecylphosphocholine (HePC) liposomes against human xenografts on Scid mice.
Papagiannaros A; Hatziantoniou S; Lelong-Rebel IH; Papaioannou GT; Dimas K; Demetzos C
In Vivo; 2006; 20(1):129-35. PubMed ID: 16433041
[TBL] [Abstract][Full Text] [Related]
38. Freeze-dried eudragit-hyaluronan multicompartment liposomes to improve the intestinal bioavailability of curcumin.
Catalan-Latorre A; Ravaghi M; Manca ML; Caddeo C; Marongiu F; Ennas G; Escribano-Ferrer E; Peris JE; Diez-Sales O; Fadda AM; Manconi M
Eur J Pharm Biopharm; 2016 Oct; 107():49-55. PubMed ID: 27349806
[TBL] [Abstract][Full Text] [Related]
39. Liposomal delivery system enhances anti-inflammatory properties of curcumin.
Basnet P; Hussain H; Tho I; Skalko-Basnet N
J Pharm Sci; 2012 Feb; 101(2):598-609. PubMed ID: 21989712
[TBL] [Abstract][Full Text] [Related]
40. In vitro determination of the efficacy of scorpion venoms as anti-cancer agents against colorectal cancer cells: a nano-liposomal delivery approach.
Al-Asmari AK; Ullah Z; Al Balowi A; Islam M
Int J Nanomedicine; 2017; 12():559-574. PubMed ID: 28144138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
